New Zealand markets close in 3 hours 23 minutes

Anebulo Pharmaceuticals, Inc. (ANEB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.8000+0.1300 (+4.87%)
At close: 04:00PM EDT
2.6600 -0.14 (-5.00%)
After hours: 05:54PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
Total revenue
0
0
0
0
Operating expenses
Research development
4,498
5,600
2,962
2,270
Selling general and administrative
4,964
6,183
3,870
1,344
Total operating expenses
9,463
11,784
6,831
3,614
Operating income or loss
-9,463
-11,784
-6,831
-3,614
Interest expense
-
-
0
11.767
Total other income/expenses net
8.187
-41.146
-1.777
-26,628
Income before tax
-9,347
-11,732
-6,826
-30,253
Income from continuing operations
-9,347
-11,732
-6,826
-30,253
Net income
-9,347
-11,732
-6,826
-30,253
Net income available to common shareholders
-9,347
-11,732
-6,826
-38,461
Basic EPS
-0.46
-0.47
-0.29
-2.83
Diluted EPS
-0.46
-0.47
-0.29
-2.83
Basic average shares
25,629
25,074
23,345
13,613
Diluted average shares
25,629
25,074
23,345
13,613